Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Brands Says Some OTC Brands Will Go, But Major Lines Will Stay

This article was originally published in The Tan Sheet

Executive Summary

Prestige Brands looks to shed less profitable brands, including personal care products, and shift resources to Chloraseptic sore throat remedies and its other major OTC brands and household lines

You may also be interested in...



Prestige Brands Replaces CEO Due To Differences With Board

Prestige Brands Holdings' second change in the CEO post in three years may spark questions, but could help the company rebuild, a market analyst says

Prestige Brands Replaces CEO Due To Differences With Board

Prestige Brands Holdings' second change in the CEO post in three years may spark questions, but could help the company rebuild, a market analyst says

Prestige Brands Replaces CEO Due To Differences With Board

Prestige Brands Holdings' second change in the CEO post in three years may spark questions, but could help the company rebuild, a market analyst says

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel